IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor (Q35979027)

11 August 2017

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor (English)

1 reference

11 August 2017

1 reference

retroperitoneal fibrosis

1 reference

Rivka Ayalon

2

0 references

Laurence H Beck

object named as

Laurence H Beck

3

0 references

Donald B Bloch

object named as

Donald B Bloch

5

0 references

David J Salant

object named as

David J Salant

4

0 references

author name string

Arezou Khosroshahi

1

1 reference

PMC publication ID

3357948

11 August 2017

John H Stone

6

1 reference

11 August 2017

10 May 2012

1 reference

International journal of rheumatology

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

139409

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Consensus statement on the pathology of IgG4-related disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Clinicopathological findings of immunoglobulin G4-related kidney disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Anti-phospholipase A2 receptor antibody in membranous nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Membranous nephropathy: recent travels and new roads ahead

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy

2 October 2017

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Proposal for diagnostic criteria for IgG4-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Tubulointerstitial nephritis associated with IgG4-related systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

A clinical overview of IgG4-related systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3357948

Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort Study

24 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

Membranous Nephropathy Associated With IgG4-Related Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F139409

High serum IgG4 concentrations in patients with sclerosing pancreatitis

21 January 2018

1 reference

12 December 2020

Nephropathy in IgG4-related systemic disease

1 reference

12 December 2020

1 reference

12 December 2020

A new clinicopathological entity of IgG4-related autoimmune disease

1 reference

12 December 2020

Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/139409

1 reference

11 August 2017

1 reference

PMC publication ID

3357948

11 August 2017

PubMed publication ID

22654915

1 reference

PMC publication ID

3357948